FORTIS vs MEDANTA: Stock Comparison

Fortis Healthcare Limited vs Global Health Limited

Live data: 16 July 2026, 11:26 AM IST • Source: NSE and company filings

Fortis Healthcare Limited is the larger company by market capitalisation. Fortis Healthcare Limited shows a higher dividend yield, while Global Health Limited shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Fortis Healthcare Limited and Global Health Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, FORTIS is more favourable on 5 of 13 scored metrics and MEDANTA on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
FORTIS is the larger company
₹73,197 Cr vs ₹35,752 Cr
P/E Ratio
MEDANTA has a lower P/E
63.9x vs 70.43x
P/B Ratio
FORTIS has a lower P/B
7.42x vs 8.97x
EPS
MEDANTA has higher earnings per share
₹20.62 vs ₹13.78
Dividend Yield
FORTIS has a higher dividend yield
0.11% vs 0.04%
Revenue Growth (TTM YoY)
MEDANTA has faster revenue growth
24.5% vs 17.8%
EPS Growth (TTM YoY)
FORTIS has faster EPS growth
44.3% vs 42%
Qtr Sales Growth
MEDANTA has stronger quarterly sales growth
24.5% vs 17.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFORTISMEDANTA
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricFORTISMEDANTA
Live Price₹967.8₹1,331.7
Day Change-0.86%-0.51%
Volume1.9 L13,312
52-Week High₹1,104.3₹1,456.5
52-Week Low₹766.8₹956
Distance from 52W High-12.36%-8.57%

Valuation

MetricFORTISMEDANTA
Market Cap₹73,197 Cr₹35,752 Cr
P/E Ratio70.43x63.9x
P/B Ratio7.42x8.97x
EPS₹13.78₹20.62
Book Value₹131.07₹147.47
Dividend Yield0.11%0.04%

Growth

MetricFORTISMEDANTA
Revenue Growth (TTM YoY)17.8%24.5%
EPS Growth (TTM YoY)44.3%42%
Qtr Sales Growth17.8%24.5%
Qtr Profit Growth22.4%4.71%

Profitability & Leverage

MetricFORTISMEDANTA
ROE11.3%15.2%
ROCE13.5%17.1%
Net Margin11.41%12.62%
Operating Margin22.8%20.8%
Debt to Equity0x0x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricFORTISMEDANTA
Promoter Holding0%33.01%
FII Holding25.97% 1.87 pp10.15% 0.38 pp
DII Holding31.35% 2.02 pp14.76% 0.76 pp
Public Holding11.51% 0.16 pp42% 0.4 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Fortis Healthcare Limited and Global Health Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.